Germany
Japan
United Kingdom
China
Antibodies
View as table Download
USD 524.00
In Stock
USD 509.00
In Stock
USD 524.00
In Stock
USD 509.00
In Stock
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
| Applications | ELISA, FC, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD3 epsilon (Clone UCHT1)
| Applications | FC, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD200R (Clone OX108)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD3 epsilon (Clone OKT-3 (muromonab))
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD52 (Clone Campath-1H)
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Active filters
Category
- Antibodies
Reactivities
- Human
Applications
- FC
Antibody Hosts
- Rabbit
Clonalities
- Monoclonal
Conjugates
- Unconjugated
Filter by
Target Symbol
- CD38 (6)
- CD4 (6)
- EGFR (5)
- TNFRSF17 (5)
- CD22 (4)
- CD52 (4)
- IL2RA (4)
- IL3RA (4)
- CD19 (3)
- CD37 (3)
- CD3E (3)
- CD40 (3)
- CD40LG (3)
- SLAMF7 (3)
- AOC3 (2)
- CASP3 (2)
- CCR5 (2)
- CD33 (2)
- CD44 (2)
- CD53 (2)
- CD63 (2)
- CD74 (2)
- CD81 (2)
- EPCAM (2)
- ERBB2 (2)
- FCER1G (2)
- ITGB7 (2)
- MS4A4A (2)
- MUC1 (2)
- TAG72 (2)
- TNFRSF8 (2)
- VEGFA (2)
- ABCB1 (1)
- ABCD3 (1)
- ACKR1 (1)
- ACTC1 (1)
- ADRB2 (1)
- AFP (1)
- AGER (1)
- BAD (1)
- BRD4 (1)
- C3AR1 (1)
- C5AR1 (1)
- CCR3 (1)
- CD15 (1)
- CD16 (1)
- CD1A (1)
- CD2 (1)
- CD200R1 (1)
- CD27 (1)
- CD274 (1)
- CD28 (1)
- CD34 (1)
- CD59 (1)
- CD7 (1)
- CD8 (1)
- CD80 (1)
- CD8A (1)
- CDC25C (1)
- CEA (1)
- CLEC4A (1)
- CLEC4M (1)
- CR1 (1)
- CXCR1 (1)
- CXCR2 (1)
- EPHA2 (1)
- FAS (1)
- FCAR (1)
- FCGR1A (1)
- FCGR2B (1)
- FOXP1 (1)
- FOXP2 (1)
- FOXP4 (1)
- FTL (1)
- HBA1 (1)
- HLA CLASS II (1)
- HSF1 (1)
- IFNG (1)
- IGM (1)
- IL11RA (1)
- IL16 (1)
- IL7R (1)
- IL9 (1)
- IRS2 (1)
- ITGA2B (1)
- ITGA4 (1)
- ITGA5 (1)
- ITGAL (1)
- ITGAV (1)
- ITGB1 (1)
- ITGB2 (1)
- KRT7 (1)
- L1CAM (1)
- L3MBTL1 (1)
- LAMB1 (1)
- LEWIS A/B (1)
- LMO2 (1)
- LTA (1)
- MAP2K4 (1)
- MARCO (1)
Isotypes
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (47)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (17)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (16)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (16)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (9)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (3)
- Phospho-specific (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Families
- Druggable Genome (21)
- Transmembrane (5)
- ES Cell Differentiation/IPS (4)
- Protein Kinase (4)
- Secreted Protein (4)
- Stem cell - Pluripotency (3)
- Phosphatase (2)
- Protease (2)
- Transcription Factors (2)
- Embryonic stem cells (1)
- Induced pluripotent stem cells (1)
- Stem cell relevant signaling - JAK/STAT signaling pathway (1)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (1)
- Stem cell relevant signaling - Wnt Signaling pathway (1)
Pathways
- Pathways in cancer (9)
- Focal adhesion (5)
- Insulin signaling pathway (5)
- Colorectal cancer (4)
- ErbB signaling pathway (4)
- MAPK signaling pathway (4)
- Acute myeloid leukemia (3)
- Adipocytokine signaling pathway (3)
- Alzheimer's disease (3)
- Amyotrophic lateral sclerosis (ALS) (3)
- Apoptosis (3)
- Epithelial cell signaling in Helicobacter pylori infection (3)
- Hypertrophic cardiomyopathy (HCM) (3)
- Small cell lung cancer (3)
- mTOR signaling pathway (3)
- Bladder cancer (2)
- Cell cycle (2)
- Chronic myeloid leukemia (2)
- Cytokine-cytokine receptor interaction (2)
- Dilated cardiomyopathy (2)
- ECM-receptor interaction (2)
- Endometrial cancer (2)
- Huntington's disease (2)
- Jak-STAT signaling pathway (2)
- Natural killer cell mediated cytotoxicity (2)
- Neurotrophin signaling pathway (2)
- Oocyte meiosis (2)
- Pancreatic cancer (2)
- Parkinson's disease (2)
- Prostate cancer (2)
- Regulation of actin cytoskeleton (2)
- Type II diabetes mellitus (2)
- VEGF signaling pathway (2)
- Viral myocarditis (2)
- Wnt signaling pathway (2)
- p53 signaling pathway (2)
- ABC transporters (1)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (1)
- Basal cell carcinoma (1)
- Cardiac muscle contraction (1)
- Cell adhesion molecules (CAMs) (1)
- Fc epsilon RI signaling pathway (1)
- Glioma (1)
- GnRH signaling pathway (1)
- Hedgehog signaling pathway (1)
- Hematopoietic cell lineage (1)
- Long-term potentiation (1)
- Melanogenesis (1)
- Melanoma (1)
- Non-small cell lung cancer (1)
- Nucleotide excision repair (1)
- Prion diseases (1)
- Progesterone-mediated oocyte maturation (1)
- Regulation of autophagy (1)
- Renal cell carcinoma (1)
- TGF-beta signaling pathway (1)
- Thyroid cancer (1)
- Toll-like receptor signaling pathway (1)
- Vascular smooth muscle contraction (1)